APOC2 and gastric cancer: CD36 has been reported to regulate PI3K/AKT signaling in tumor progression,31, 32 but the exact interaction between APOC2 and CD36 as well as subsequent effect on PI3K/AKT/mTOR signaling in GC have not been investigated.